Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Multiple Myeloma × abemaciclib × Clear all

Phase

Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 13 Brain Neoplasms 4 Neoplasm Metastasis 3 Ovarian Neoplasms 2 Glioma 2 Glioblastoma 2 Endometrial Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Triple Negative Breast Neoplasms 1 Solid Tumor, Adult 1 Sarcoma, Kaposi 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Osteosarcoma 1 Neuroblastoma 1 Neoplasms by Site 1 Neoplasms 1 Multiple Myeloma 1 Medulloblastoma 1 Lung Neoplasms 1 Liposarcoma 1 Leiomyosarcoma 1 Fallopian Tube Neoplasms 1 Ependymoma 1 ER+ HER2- Advanced Breast Cancer 1

Interventions

Dexamethasone 95 Lenalidomide 45 Bortezomib 42 Melphalan 36 Calcium Dobesilate 32 Cyclophosphamide 28 carfilzomib 27 pomalidomide 26 daratumumab 17 belantamab mafodotin 17 Peripheral Blood Stem Cell Transplantation 15 ixazomib 13 fludarabine 12 Tacrolimus 11 Filgrastim 11 Bendamustine Hydrochloride 11 dexamethasone acetate 10 Whole-Body Irradiation 10 fludarabine phosphate 9 dexamethasone 21-phosphate 9 auricularum 9 Prednisone 9 selinexor 8 iberdomide 8 venetoclax 7 Granulocyte Colony-Stimulating Factor 7 liposomal doxorubicin 6 elotuzumab 6 Stem Cell Transplantation 6 Sirolimus 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03732703 2025-02-14

MyDRUG

Multiple Myeloma Research Consortium

Phase 1/2 Completed

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡